TMoC-Lite is a tumor-on-chip system that simulates real tumor microenvironment physiology for preclinical drug evaluation and personalized cancer treatment assessment. The platform accelerates immunotherapy development and personalized oncology applications through ex vivo tissue modeling.
Manufactured by
Fluidiconic Biotechnology Co., Ltd.
Hsinchu City, Taiwan
At Fluidiconic, we reimagine preclinical evaluation with human-relevant microfluidic platforms—accelerating oncology breakthroughs beyond the limits of animal testing. By combining dynamic 3D tumor culture, immune cell integration, and spatial heterogeneity modeling, our MedSelect platform simulates critical human responses that animal models often miss. It helps researchers gain earlier insights, reduce animal usage, and confidently advance next-generation immunotherapies and precision oncology solutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangsu Avatarget Biotechnology Limited Liability Company
China · 1 relevant product
Fraunhofer IWS Fraunhofer-Institut für Werkstoff- und Strahltechnik IWS
Germany · 1 relevant product
NOROVA
China · 1 relevant product
7 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 12 closest product alternatives
Jiangsu Avatarget Biotechnology Limited Liability Company · China
Cancer organoid growth kit utilizing organ-on-chip technology to create high-fidelity human tissue models for drug efficacy evaluation and clinical treatment planning. Enables personalized medicine through rapid assessment of therapeutic response and toxicity in cancer research and oncology applications.
Fraunhofer IWS Fraunhofer-Institut für Werkstoff- und Strahltechnik IWS · Germany
Technology platform for developing and testing microphysiological systems that simulate human organ and tissue behavior in vitro. Enables preclinical drug testing, toxicology assessment, and disease modeling with improved physiological relevance compared to conventional cell cultures. Integrates microfluidics, tissue engineering, and analytical capabilities for pharmaceutical and biomedical research applications.
NOROVA · China
A three-dimensional in vitro cell culture system that establishes patient-derived tumor organoid models highly similar to patient tumor characteristics. The tumor organoids maintain high consistency with patient tumor pathological, molecular, and genetic features while enabling personalized drug sensitivity assessment, with reported accuracy up to 80%.
9 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products